
PROCEPT BioRobotics Faces Class Action Over Inventory Practices
Investors have launched a class action lawsuit against PROCEPT BioRobotics, alleging the medical device manufacturer artificially inflated revenue through bulk-discount schemes that masked excess customer inventory. The complaint targets statements made between February 28, 2024, and February 25, 2026, following a 48% drop in the company’s share price.

























